IRW-PRESS: Midpoint Holdings Ltd .: Midpoint Holdings Ltd .: Appointment of Mr. Derek Ivany to the Board of Directors
London, United Kingdom (April 14, 2021) – Midpoint Holdings Ltd. (TSXV: MPT) (Midpoint as the company) is pleased to announce the following changes to its board of directors and executives:
– Appointment of Derek Ivany as Director, Chairman of the Audit Committee and Renumeration Committee of the company;
– Michael Hampson is stepping down as director of the company.
The company is pleased that Mr. Ivany is welcome on her board of directors and as chair of its Audit Committee and Compensation Committee.
Mr. Ivany served mostly as chairman of the Midpoint Advisory Board. In this role, he played an important role in the refinancing of the company. In his new role, Mr Ivany will focus on Midpoint’s growing market and business offerings, with a particular focus on assessing strategic and synergistic opportunities within the growing FinTech and Crypto-currency sectors.
I’m really looking forward to focusing on leading Midpoint in the next phase of its growth, says Derek Ivany. Going forward, David Wong and his team have done an excellent job and maintained a versatile payment platform that will provide a strong foundation for future value-adding opportunities. As a long-time shareholder of Midpoint, I am particularly looking forward to working with the team to increase the value of the company for the benefit of all involved. I think Midpoint is well positioned to take advantage of the downturn in the financial technology sector.
Mr. Ivany was previously the president and CEO of a publicly traded company whose valuation of its $ 2 million in market cap to $ 250 million peaked during its tenure. At the same time, a lot of liquidity was generated for investors. Last year, he was responsible for more than $ 15 million in wealth accumulation across a variety of commercial banking mandates in the biotechnology, health and wellness, and technology sectors. Derek’s most extensive roles include his appointment to the Advisory Board of Relay Medical Corp., where he was instrumental in the growth financing of the company, and as founder and CEO of Holy Crap Brands Inc., operated by Plant & Co Brands Ltd . was taken over. There he now contributes to the direction of business development and strategy. In addition, Mr. Ivany was the founder and president of Pilz BioScience Corp., a biotechnology company that developed medical psychedelics for the treatment of disorders with a neuro-inflammatory component, with an initial focus on disorders of the autistic spectrum. Mushroom BioScience was founded by Nova Mentis Life Science Corp. accepted.
In comments on the appointment of Mr. Ivany said David Wong, CEO of Midpoint: Derek has extensive experience and an impressive track record. I look forward to working with Derek to create exceptional value for our shareholders. Like myself, Derek was a Midpoint client before becoming an investor and now joining the Midpoint team. This speaks volumes about Midpoint’s value proposition and the company’s vision.
The company would also like to thank Mr. Hampson for his valuable contributions to the company. It has been a pleasure to be part of the Midpoint team and to guide the company in its global expansion over the years. I will continue the business as a client and shareholder as I focus on the next phase of Bishopsgate Financial, my consulting firm, and other companies in the pipeline. I would like to welcome and congratulate Derek Ivany on his appointment to the Council. I would also like to take this opportunity to thank David for his dedication to Midpoint and the incredible work he has done to restructure the company – the results speak for themselves. I look forward to the continued success and growth of Midpoint over the coming years, ”Mr Hampson said.
It has been a real honor and pleasure to work with Mike. On behalf of Midpoint, we wish Mr Hampson all the best for the future and we would like to welcome an opportunity to work together in the future, says CEO David Wong.
Midpoint, based in London, United Kingdom, is an authorized FCA payment institution specializing in cross-border payments and forex trading. SMEs, overseas professionals, homeowners, overseas students, individuals and anyone involved in international payments use Midpoint’s U.S. patent-protected platform for transparent, multi-party and multi-currency transparent services.
Midpoint currently processes transactions in 26 currencies and can collect and transfer payments in more than 200 countries. This highly secure platform offers clients the most cost-effective FX transactions at the midpoint of the interbank rate / selling ratio, eliminating the spread and hiding hidden costs and fees.
Midpoint Holdings Limited is listed on the TSX Venture Exchange and has a secondary listing on the Frankfurt Stock Exchange.
Additional information is available at:
Corbin Comishin, CFO David Wong, President and CEO
Midpoint Holdings Limited, 22-25 Portman Close,
505 Kootenay Street, Nelson, London W1H 6BS, United
British Columbia V1L 1K9, Tel: 0044 20 7448 3082
Tel: 001 250 352 7667 Email: [email protected]
The TSX Venture Exchange (the TSXV) and its regulatory bodies (designated as the Provider of Regulatory Services in the Articles of Association of TSXV) take no responsibility for the adequacy or accuracy of this news release and have neither approved nor disapproved of its contents.
This press release contains certain prior information within the meaning of applicable Securities Act. Progressive information is often characterized by terms such as plan, expect, predict, intend, believe, anticipate, estimate, possibly, will, would, potentially, planned, as well as similar terms or statements by which certain events or conditions may or will occur. These statements are forecasts only. Progressive information is based on the opinions and estimates of the management at the time this information was made available and is subject to a number of risks and uncertainties and other factors that may cause actual events or results to differ materially from those in the forward-looking information is provided. Readers will find a description of the risks and uncertainties that Midpoint faces in the course of their business in Midpoint’s Managements Discussion & Analysis. Midpoint has no obligation to update prior information if circumstances change as estimates or opinions of management change, except as required by law. Readers are warned that forward-looking information is unreliable.
Not for distribution in the United States or through U.S. intelligence services. Failure to comply with this restriction may result in a violation of U.S. Securities Act.
The source language (mostly English) in which the original text is published is the official, authorized and legally valid version. This translation is included for better understanding. The German version may be abbreviated or summarized. No liability or liability is assumed for the content, accuracy, suitability or accuracy of this translation. From the translator’s point of view, the message is not a buy or sell recommendation! Note the original English report at www.sedar.com, www.sec.gov, www.asx.com.au/ or on the company’s website!
The original English report can be found under the following link:
The translated message can be found under the following link:
Current press releases from this company directly in your inbox:
Announcement sent by IRW-Press.com. The broadcaster is responsible for the content.
Free reprints allowed provided the source is acknowledged.
AXC0372 2021-04-14 / 20:34
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republishing or permanent storage without the express prior consent of dpa-AFX is not permitted.